MTARC1
protein-codingmitochondrial amidoxime reducing component 1
Gene summary
Enables molybdenum ion binding activity; molybdopterin cofactor binding activity; and oxidoreductase activity, acting on other nitrogenous compounds as donors. Contributes to nitrite reductase (NO-forming) activity. Involved in cellular detoxification of nitrogen compound; nitrate metabolic process; and nitric oxide biosynthetic process. Located in mitochondrion. Part of nitric-oxide synthase complex. [provided by Alliance of Genome Resources, Jul 2025]
- MOSC1
- MARC1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~33.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MTARC1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_022746.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 49 | 2 | 2 | 53 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 0 | 0 | 52 | 2 | 4 | 58 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_073583.3 | 7 | MANE Select | |
| Ensembl | ENSP00000355877.5 | 7 | MANE Select | |
| Ensembl | ENSP00000385327.2 | 6 | Standard | |
| Ensembl | ENSP00000409634.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Phase I - Functionalization of compounds
- Biological oxidations
- Metabolism
Biological Process
- nitrate metabolic process
- detoxification of nitrogen compound
- oxidation-reduction process
Molecular Function
- nitrate reductase activity
- molybdenum ion binding
- pyridoxal phosphate binding
- molybdopterin cofactor binding
Cellular Component
- mitochondrion
- mitochondrial outer membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000366910
- Coding exons
- 7
- Length
- 27635
- Individuals with no LoFs
- 125651
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 96
- Defined
- 125748
- p
- 0.000386
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.584 | 151 | 173 | 0.875 | 0.00000958 | 2110 |
| Missense (PolyPhen) | 32 | 47.404 | 0.67505 | 574 | ||
| Synonymous | 0.819 | 64 | 72.9 | 0.878 | 0.00000432 | 723 |
| Loss of Function | 0.740 | 13 | 16.2 | 0.802 | 9.45e-7 | 177 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00042 | 0.00040 | rare |
| Ashkenazi Jewish | 0.0048 | 0.0047 | notable |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.00019 | 0.00018 | rare |
| European (Non-Finnish) | 0.00015 | 0.00015 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0.0010 | 0.00081 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: As a component of an N-hydroxylated prodrug-converting complex required to reduce N-hydroxylated prodrugs, such as benzamidoxime. Also able to reduce N(omega)-hydroxy-L-arginine (NOHA) and N(omega)-hydroxy-N(delta)-methyl-L-arginine (NHAM) into L-arginine and N(delta)-methyl-L-arginine, respectively. {ECO:0000269|PubMed:19053771}.;
Recessive Scores
- pRec
- 0.100
Intolerance Scores
- RVIS EVS
- 0.11
- RVIS percentile EVS
- 61.91
Essentials
- Essential (CRISPR)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |